Eli Lilly’s Path to $2 Trillion: Can GLP-1 Dominance Fuel the Next Trillion-Dollar Leap by 2031?
Eli Lilly and Company (NYSE: LLY) made history in 2024 as the first healthcare stock to breach the $1 trillion market capitalization milestone. While the stock has consolidated since that peak, a compelling bull case suggests the Indianapolis-based pharmaceutical giant could double its valuation to $2 trillion by 2031. This projection implies a compound annual … Read more

